Table 3A.

Change in cutaneous, physician, and parent/patient scores from baseline to last visit in each CTP based upon intent to treat (n = 44).

Measure	Visit	All Patients, n = 44	A: MTX, n = 12	B: MTX + IV CS, n = 23	C: MTX + PO CS, n = 9
PGA-A	Baseline	4.5 (4–6)	4 (2.5–5)	6 (4–7)	4 (4–5)
PGA-A	Last	0.5 (0–2)^*	1 (0–1.5)^*	1 (0–3)^*	0 (0–1)^{^}
mLoSSI	Baseline	7 (4–10)	6.5 (2–11.5)	9 (5–11)	5 (5–6)
mLoSSI	Last	0 (0–2)^*	0.5 (0–1.5)^*	0 (0–2)^*	0 (0–0)^*
LSCAM	Baseline^¹	7 (4–13.5)	8.5 (6–11.5)	9 (4–17)	4 (4–5)
LSCAM	Last^¹	2 (0–4)^*	2 (0.5–3)^*	2 (1–4)^*	0 (0–1)^{^}
PGA-D	Baseline	4 (3–5.5)	4 (2.5–4.5)	4 (3–7)	3 (2–5)
PGA-D	Last^¹	3 (2–5)	3.5 (1–5.5)	4 (3–6)	3 (1–3)
LoSDI	Baseline	8 (3–14.5)	10.5 (5.5–15)	12 (3–8)	4 (2–7)
LoSDI	Last	8 (4–13.5)	7 (4–10)	10 (5–17)	4 (3–9)
LSDam	Baseline^¹	11 (4.5–17)	13.5 (7–17)	15 (5–23)	7 (4–9)
LSDam	Last^¹	9 (5–15)	8.5 (4.5–11.5)	11 (5–19)	6 (3–9)
Overall global health	Baseline	2 (1–2)	2 (1–2)	2 (1–3)	2 (1–2)
Overall global health	Last	2 (1.5–2)	2 (1–2)	2 (2–3)	2 (2–2)
Impact of rheumatic disease	Baseline	1 (0–3)	1 (0–2)	1 (0–5)	0 (0–3)
Impact of rheumatic disease	Last	1 (0–2)	1 (0–1)	2 (1–2)	0 (0–1)